Dermatology

Latest News

New Option for Chronic Hand Eczema Gets FDA Green Light: Daily Dose / image credit: ©New Africa/AdobeStock
New Option for Chronic Hand Eczema Gets FDA Green Light: Daily Dose

August 1st 2025

Your daily dose of the clinical news you may have missed.

FDA Approves Delgocitinib, First Treatment for Adults with Moderate to Severe Chronic Hand Eczema / image credit  ©Waldenmarus/Shutterstock.com
FDA Approves Delgocitinib, First Treatment for Adults With Moderate to Severe Chronic Hand Eczema

July 24th 2025

Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings / image credit Courtesy of Bispebjerg Hospital
Atopic Dermatitis Flare Frequency May Predict Future Disease Severity, According to New Findings

July 21st 2025

Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose / image credit: ©New Africa/AdobeStock
Lebrikizumab Maintains Skin Clearance Through 3 Years in AD Patients: Daily Dose

July 21st 2025

Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose / image credit: ©New Africa/AdobeStock
Dupilumab Sustains Long-Term Reduction of S. aureus in People with AD: Daily Dose

July 16th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.